Bonus Issues

IND-SWIFT LABORATORIES LTD.

NSE : INDSWFTLABBSE : 532305ISIN CODE : INE915B01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE124.951.79 (+1.45 %)
PREV CLOSE ( ) 123.16
OPEN PRICE ( ) 123.09
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 55638
TODAY'S LOW / HIGH ( )122.60 126.70
52 WK LOW / HIGH ( )63.4 138.25
NSE124.351.25 (+1.02 %)
PREV CLOSE( ) 123.10
OPEN PRICE ( ) 122.50
BID PRICE (QTY) 124.35 (351)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 454643
TODAY'S LOW / HIGH( ) 122.50 126.65
52 WK LOW / HIGH ( )63 138.45

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.